Our therapeutic plasma exchange protocols have been built through over 10 years of established clinical practice and rigorous medical evidence in the United States by a leader in the field of apheresis and therapeutic plasma exchange.

TPE has been safely used in healthcare for over 40 years, with extensive clinical experience and more than 1.2 million procedures performed annually, worldwide. MyLongevity's approach follows evidence-based guidelines developed by the American Society for Apheresis and international medical standards, ensuring every treatment meets the highest levels of clinical excellence and patient safety.

Our medical team utilizes state-of-the-art apheresis technology with continuous monitoring systems, standardised anticoagulation protocols and comprehensive pre-treatment screening to maximise safety outcomes for all of our patients, along with guidance by one of the World's foremost experts in the field as our Consulting Physician (Dr Dobri Kiprov of Global Apheresis Inc).

Each procedure follows established clinical guidelines that have been refined through thousands of treatments across multiple medical specialties.

Our commitment to clinical soundness extends beyond individual treatments to encompass the entire patient journey. We employ comprehensive health assessments, advanced biomarker testing, and personalized treatment protocols based on each patient's unique health profile.

The systematic and safe approach utilised through Dr Kiprov's research, combined with ongoing monitoring and post-treatment care, ensures that every aspect of our TPE program meets the rigorous standards expected in modern medical practice while delivering the therapeutic benefits supported by clinical research.